Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.
Insights into the mechanisms of amyotrophic lateral sclerosis (ALS) have relied predominantly on the study of postmortem tissue. Modern technology has improved the ability of scientists to probe effectively the underlying biology of ALS by examination of genomic, proteomic and physiological changes...
Main Authors: | Bowser, R, Turner, M, Shefner, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.
by: Turner, M, et al.
Published: (2013) -
Biomarkers in amyotrophic lateral sclerosis.
by: Turner, M, et al.
Published: (2009) -
Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis
by: Thompson, AG, et al.
Published: (2021) -
Quantifying disease progression in amyotrophic lateral sclerosis.
by: Simon, N, et al.
Published: (2014) -
Motor system biomarkers in amyotrophic lateral sclerosis
by: Edmond, EC, et al.
Published: (2019)